In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Astera Labs Inc (NASDAQ: ALAB) closed at $152.51 in the last session, up 0.01% from day before closing price of $152.5. In other words, the price has increased by $0.01 from its previous closing price. On the day, 3.8 million shares were traded. ALAB stock price reached its highest trading level at $154.0 during the session, while it also had its lowest trading level at $147.0.
Ratios:
We take a closer look at ALAB’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 22.69 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 112.27. For the most recent quarter (mrq), Quick Ratio is recorded 12.27 and its Current Ratio is at 12.78. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
On November 20, 2025, BNP Paribas Exane started tracking the stock assigning a Outperform rating and target price of $225.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 01 ’25 when ALBA MANUEL sold 33,000 shares for $166.18 per share. The transaction valued at 5,483,981 led to the insider holds 352,863 shares of the business.
ALBA MANUEL sold 150,000 shares of ALAB for $24,927,221 on Dec 01 ’25. The Director now owns 1,574,498 shares after completing the transaction at $166.18 per share. On Dec 01 ’25, another insider, MAR 2011 CHILDRENS TRUST U/A D, who serves as the Director of the company, bought 170,000 shares for $157.57 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALAB now has a Market Capitalization of 25759490048 and an Enterprise Value of 24656384000. As of this moment, Astera’s Price-to-Earnings (P/E) ratio for their current fiscal year is 135.78, and their Forward P/E ratio for the next fiscal year is 62.63. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.30. For the stock, the TTM Price-to-Sale (P/S) ratio is 35.63 while its Price-to-Book (P/B) ratio in mrq is 20.26. Its current Enterprise Value per Revenue stands at 34.101 whereas that against EBITDA is 221.003.
Stock Price History:
The Beta on a monthly basis for ALAB is 1.57, which has changed by 0.26661134 over the last 52 weeks, in comparison to a change of 0.12469888 over the same period for the S&P500. Over the past 52 weeks, ALAB has reached a high of $262.90, while it has fallen to a 52-week low of $47.12. The 50-Day Moving Average of the stock is -11.16%, while the 200-Day Moving Average is calculated to be 21.04%.
Shares Statistics:
According to the various share statistics, ALAB traded on average about 6.59M shares per day over the past 3-months and 7984840 shares per day over the past 10 days. A total of 168.90M shares are outstanding, with a floating share count of 133.46M. Insiders hold about 20.98% of the company’s shares, while institutions hold 65.99% stake in the company. Shares short for ALAB as of 1763078400 were 10645508 with a Short Ratio of 1.62, compared to 1760486400 on 9260453. Therefore, it implies a Short% of Shares Outstanding of 10645508 and a Short% of Float of 8.520000399999999.
Earnings Estimates
The stock of Astera Labs Inc (ALAB) is currently being evaluated by 19.0 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is $0.52, with high estimates of $0.56 and low estimates of $0.47.
Analysts are recommending an EPS of between $1.8 and $1.76 for the fiscal current year, implying an average EPS of $1.78. EPS for the following year is $2.37, with 19.0 analysts recommending between $2.81 and $2.0.
Revenue Estimates
According to 17 analysts,. The current quarter’s revenue is expected to be $249.46M. It ranges from a high estimate of $251.3M to a low estimate of $248.9M. As of. The current estimate, Astera Labs Inc’s year-ago sales were $141.1MFor the next quarter, 17 analysts are estimating revenue of $258.71M. There is a high estimate of $266.45M for the next quarter, whereas the lowest estimate is $249.1M.
A total of 21 analysts have provided revenue estimates for ALAB’s current fiscal year. The highest revenue estimate was $833.3M, while the lowest revenue estimate was $774.54M, resulting in an average revenue estimate of $827.5M. In the same quarter a year ago, actual revenue was $396.29MBased on 19 analysts’ estimates, the company’s revenue will be $1.18B in the next fiscal year. The high estimate is $1.33B and the low estimate is $1.07B.
